Though the amount of primary (fresh) mesenchymal stem cells within a SVF (Stromal Vascular Fraction) isolated from the patients fat is relatively small when compared to the millions of culture expanded cells, it still is the most commonly office stem cell therapy practiced by physicians within the US territory. This form of stem cells therapy is “minimally manipulated” (not culture expanded), isolated and transplanted back to the patient within the same day. US medical authorities tend to see this procedure as “medical practice” and no major opposition exist at this time.
ISCELLI’s protocols for Primary Stem Cell Therapy with bone marrow and adipose tissue are limited to a number of soft tissue/skin/joints conditions (arthritis, chronic wounds, eye disease, lung disease) and some autoimmune and vascular conditions. Though significantly successful when injected locally (knee arthritis, p.e) this primary SVF/stem cell therapy alone may not necessarily provide sufficient number of stem cells to approach body generalized and chronic diseases (Autism Parkinson’s, Multiple Sclerosis, Alzheimer’s disease, or advanced Osteoarthritis, among others.)